Menu

Blog

Archive for the ‘biotech/medical’ category: Page 123

Jul 9, 2024

Novel ‘kill-switch’ nanorobot selectively kills cancer cells

Posted by in categories: biotech/medical, robotics/AI

Researchers have developed a pH-responsive nanorobot system that changes confirmation in the tumor microenvironment to selectively kill cancer cells in mice.

Researchers at the Karolinska Institutet (Stockholm, Sweden) have recently developed a nanorobot system capable of killing cancer cells in mice. This system works by activating at lower pH, such as within the tumor microenvironment. It is hoped that this could serve as a proof-of-concept for similar stimulus-responsive nanorobotic approaches and introduce a new range of effective cancer therapeutics.

Certain membrane proteins capable of inducing apoptosis, a type of cell death, appear on the surface of both healthy and cancer cells. These proteins, often called death receptors, join and activate when in close proximity to each other. This closeness is induced by external factors binding to the cell surface.

Jul 9, 2024

Sustaining wakefulness: Brainstem connectivity in human consciousness

Posted by in categories: biotech/medical, chemistry, finance, neuroscience

Consciousness is comprised of arousal (i.e., wakefulness) and awareness. Substantial progress has been made in mapping the cortical networks that modulate awareness in the human brain, but knowledge about the subcortical networks that sustain arousal is lacking. We integrated data from ex vivo diffusion MRI, immunohistochemistry, and in vivo 7 Tesla functional MRI to map the connectivity of a subcortical arousal network that we postulate sustains wakefulness in the resting, conscious human brain, analogous to the cortical default mode network (DMN) that is believed to sustain self-awareness. We identified nodes of the proposed default ascending arousal network (dAAN) in the brainstem, hypothalamus, thalamus, and basal forebrain by correlating ex vivo diffusion MRI with immunohistochemistry in three human brain specimens from neurologically normal individuals scanned at 600–750 µm resolution. We performed deterministic and probabilistic tractography analyses of the diffusion MRI data to map dAAN intra-network connections and dAAN-DMN internetwork connections. Using a newly developed network-based autopsy of the human brain that integrates ex vivo MRI and histopathology, we identified projection, association, and commissural pathways linking dAAN nodes with one another and with cortical DMN nodes, providing a structural architecture for the integration of arousal and awareness in human consciousness. We release the ex vivo diffusion MRI data, corresponding immunohistochemistry data, network-based autopsy methods, and a new brainstem dAAN atlas to support efforts to map the connectivity of human consciousness.

One sentence summary We performed ex vivo diffusion MRI, immunohistochemistry, and in vivo 7 Tesla functional MRI to map brainstem connections that sustain wakefulness in human consciousness.

BF has a financial interest in CorticoMetrics, a company whose medical pursuits focus on brain imaging and measurement technologies. BF’s interests were reviewed and are managed by Massachusetts General Hospital and Mass General Brigham HealthCare in accordance with their conflict-of-interest policies.

Jul 9, 2024

The Effects of Stress on Prefrontal Cortical Function

Posted by in categories: biotech/medical, genetics, neuroscience

Learn more about the Cognitive Science Student Association and the California Cognitive Science Conference at https://cssa.berkeley.edu.

Amy Arnsten — Yale University.

Continue reading “The Effects of Stress on Prefrontal Cortical Function” »

Jul 9, 2024

Bacterial glitter: New findings open up possibilities for sustainable color technologies

Posted by in categories: biotech/medical, materials

An international team of researchers of the Cluster of Excellence “Balance of the Microverse” at the University of Jena has investigated the mechanism that makes some types of bacteria reflect light without using pigments. The researchers were interested in the genes responsible and discovered important ecological connections. Their findings appear in the Proceedings of the National Academy of Sciences.

The iridescent colors known from peacock feathers or butterfly wings are created by tiny structures that reflect light in a special way. Some form similar glittering structures.

In collaboration with the Max Planck Institute of Colloids and Interfaces, Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures, Utrecht University, University of Cambridge, and the Netherlands Institute for Sea Research, the scientists sequenced the DNA of 87 structurally colored bacteria and 30 colorless strains and identified genes that are responsible for these fascinating colonies. These findings could lead to the development of environmentally-friendly dyes and materials, a key interest of the collaborating biotechnology company Hoekmine BV.

Jul 9, 2024

Scientists Have Developed a New Type of Glass With Unique and Even Contradictory Properties

Posted by in categories: bioengineering, biotech/medical

Researchers from Tel Aviv University (TAU) have created a new type of glass with unique and even contradictory properties, such as being a strong adhesive (sticky) and incredibly transparent at the same time. The glass, which forms spontaneously when comes in contact with water at room temperature, could bring about a revolution in an array of different and diverse industries such as optics and electro-optics, satellite communication, remote sensing and biomedicine.

The glass was discovered by a team of researchers from Israel and the world, led by PhD student Gal Finkelstein-Zuta and Prof. Ehud Gazit from the Shmunis School of Biomedicine and Cancer Research at the Faculty of Life Sciences and the Department of Materials Science and Engineering at the Faculty of Engineering at TAU. The results of the research were recently published in the prestigious scientific journal Nature.

Jul 8, 2024

Bridge RNA: A new gene editing technique that could overcome the limitations of CRISPR

Posted by in categories: bioengineering, biotech/medical

Find out how the recent discovery of a bacterial molecular oddity known as bridge RNA, has led to the creation of a novel gene editing tool.

Jul 8, 2024

Lab-grown human brain tissue used to control robot

Posted by in categories: biotech/medical, robotics/AI

Scientists merged human brain-like tissue with a computer chip and taught tiny robots how to navigate obstacles and grasp items.⁠


Scientists take another step towards organoid ‘hybrid intelligence.’

Jul 8, 2024

T-cell Transfer Therapy

Posted by in category: biotech/medical

T-cell transfer therapy is a type of immunotherapy that makes your own immune cells better able to attack cancer. There are two main types of T-cell transfer therapy: tumor-infiltrating lymphocytes (or TIL) therapy and CAR T-cell therapy. Both involve collecting your own immune cells, growing large numbers of these cells in the lab, and then giving the cells back to you through a needle in your vein. T-cell transfer therapy is also called adoptive cell therapy, adoptive immunotherapy, and immune cell therapy.

The process of growing your T cells in the lab can take 2 to 8 weeks. During this time, you may have treatment with chemotherapy and, maybe, radiation therapy to get rid of other immune cells. Reducing your immune cells helps the transferred T cells to be more effective. After these treatments, the T cells that were grown in the lab will be given back to you via a needle in your vein.

Jul 8, 2024

Log In

Posted by in categories: biotech/medical, neuroscience

Toronto, Ontario —A new ultra-high-performance brain PET system allows for the direct measurement of brain nuclei as never before seen or quantified. With its ultra-high sensitivity and resolution, the NeuroEXPLORER provides exceptional brain PET images and has the potential to spur advances in the treatment of many brain diseases. This research was presented at the 2024 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, and the grouping of images highlighting targeted tracer uptake in specific brain nuclei has been selected as the 2024 SNMMI Henry N. Wagner, Jr., Image of the Year.

Each year, SNMMI chooses an image that best exemplifies the most promising advances in the field of nuclear medicine and molecular imaging. The state-of-the-art technologies captured in these images demonstrate the capacity to improve patient care by detecting disease, aiding diagnosis, improving clinical confidence, and providing a means of selecting appropriate treatments. This year, the SNMMI Image of the Year was chosen from more than 1,500 abstracts submitted for the meeting.

The image quality of PET systems has improved in recent years, mostly by increases in sensitivity, including enhanced time-of-flight capabilities. However, these systems have shown only minimal improvement in intrinsic resolution. To address these issues, researchers designed the NeuroEXPLORER PET scanner with a focus on ultra-high sensitivity and resolution, as well as continuous head motion correction.

Jul 8, 2024

An expedited screening platform for the discovery of anti-ageing compounds in vitro and in vivo

Posted by in categories: biotech/medical, genetics, information science, life extension

Restraining or slowing ageing hallmarks at the cellular level have been proposed as a route to increased organismal lifespan and healthspan. Consequently, there is great interest in anti-ageing drug discovery. However, this currently requires laborious and lengthy longevity analysis. Here, we present a novel screening readout for the expedited discovery of compounds that restrain ageing of cell populations in vitro and enable extension of in vivo lifespan.

Using Illumina methylation arrays, we monitored DNA methylation changes accompanying long-term passaging of adult primary human cells in culture. This enabled us to develop, test, and validate the CellPopAge Clock, an epigenetic clock with underlying algorithm, unique among existing epigenetic clocks for its design to detect anti-ageing compounds in vitro. Additionally, we measured markers of senescence and performed longevity experiments in vivo in Drosophila, to further validate our approach to discover novel anti-ageing compounds. Finally, we bench mark our epigenetic clock with other available epigenetic clocks to consolidate its usefulness and specialisation for primary cells in culture.

We developed a novel epigenetic clock, the CellPopAge Clock, to accurately monitor the age of a population of adult human primary cells. We find that the CellPopAge Clock can detect decelerated passage-based ageing of human primary cells treated with rapamycin or trametinib, well-established longevity drugs. We then utilise the CellPopAge Clock as a screening tool for the identification of compounds which decelerate ageing of cell populations, uncovering novel anti-ageing drugs, torin2 and dactolisib (BEZ-235). We demonstrate that delayed epigenetic ageing in human primary cells treated with anti-ageing compounds is accompanied by a reduction in senescence and ageing biomarkers. Finally, we extend our screening platform in vivo by taking advantage of a specially formulated holidic medium for increased drug bioavailability in Drosophila. We show that the novel anti-ageing drugs, torin2 and dactolisib (BEZ-235), increase longevity in vivo.

Page 123 of 2,753First120121122123124125126127Last